Akeso Future Growth
Future criteria checks 3/6
Akeso is forecast to grow earnings and revenue by 10.9% and 18.5% per annum respectively. EPS is expected to grow by 0.01% per annum. Return on equity is forecast to be 21% in 3 years.
Key information
10.9%
Earnings growth rate
0.01%
EPS growth rate
Biotechs earnings growth | 24.8% |
Revenue growth rate | 18.5% |
Future return on equity | 21.0% |
Analyst coverage | Good |
Last updated | 07 May 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 6,061 | 1,282 | 1,323 | 1,834 | 16 |
12/31/2025 | 4,279 | 260 | 122 | 292 | 18 |
12/31/2024 | 2,650 | -433 | -596 | -363 | 18 |
12/31/2023 | 4,526 | 2,028 | 1,588 | 2,468 | N/A |
9/30/2023 | 4,439 | 2,008 | 1,459 | 2,340 | N/A |
6/30/2023 | 4,351 | 1,987 | 1,330 | 2,212 | N/A |
3/31/2023 | 2,595 | 409 | -356 | 486 | N/A |
12/31/2022 | 838 | -1,168 | -2,043 | -1,240 | N/A |
9/30/2022 | 549 | -1,224 | -1,997 | -1,238 | N/A |
6/30/2022 | 260 | -1,280 | -1,952 | -1,235 | N/A |
3/31/2022 | 243 | -1,178 | -1,835 | -1,118 | N/A |
12/31/2021 | 226 | -1,075 | -1,717 | -1,001 | N/A |
9/30/2021 | 177 | -1,002 | -1,525 | -882 | N/A |
6/30/2021 | 129 | -929 | -1,333 | -762 | N/A |
3/31/2021 | 64 | -983 | -1,200 | -690 | N/A |
12/31/2020 | N/A | -1,036 | -1,066 | -618 | N/A |
9/30/2020 | 35 | -870 | -814 | -443 | N/A |
6/30/2020 | 71 | -703 | -562 | -267 | N/A |
3/31/2020 | 71 | -492 | -459 | -243 | N/A |
12/31/2019 | 71 | -282 | -356 | -220 | N/A |
12/31/2018 | 3 | -142 | -198 | -123 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AKES.F's forecast earnings growth (10.9% per year) is above the savings rate (2.4%).
Earnings vs Market: AKES.F's earnings (10.9% per year) are forecast to grow slower than the US market (14.6% per year).
High Growth Earnings: AKES.F's earnings are forecast to grow, but not significantly.
Revenue vs Market: AKES.F's revenue (18.5% per year) is forecast to grow faster than the US market (8.3% per year).
High Growth Revenue: AKES.F's revenue (18.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: AKES.F's Return on Equity is forecast to be high in 3 years time (21%)